Published in TB and Outbreaks Week, June 3rd, 2003
We are announcing further information on our contracts with the U.S. government and providing an update on contracts with other governments around the world. These are described in further detail below.
In February, we were awarded a $9.2m contract by the U.S. National Institutes of Allergy and Infectious Diseases (NIAID) relating to development of a new Modified Vaccinia Ankara (MVA) vaccine, which is a weakened form of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week